BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 20398351)

  • 1. The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial.
    Shakur H; Elbourne D; Gülmezoglu M; Alfirevic Z; Ronsmans C; Allen E; Roberts I
    Trials; 2010 Apr; 11():40. PubMed ID: 20398351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of tranexamic acid on the risk of death and hysterectomy in women with post-partum haemorrhage: statistical analysis plan for the WOMAN trial.
    Shakur H; Roberts I; Edwards P; Elbourne D; Alfirevic Z; Ronsmans C
    Trials; 2016 May; 17(1):249. PubMed ID: 27188698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial.
    WOMAN Trial Collaborators
    Lancet; 2017 May; 389(10084):2105-2116. PubMed ID: 28456509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifibrinolytic drugs for treating primary postpartum haemorrhage.
    Shakur H; Beaumont D; Pavord S; Gayet-Ageron A; Ker K; Mousa HA
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD012964. PubMed ID: 29462500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tranexamic acid for the prevention of postpartum bleeding in women with anaemia: study protocol for an international, randomised, double-blind, placebo-controlled trial.
    Ker K; Roberts I; Chaudhri R; Fawole B; Beaumont D; Balogun E; Prowse D; Pepple T; Javaid K; Kayani A; Arulkumaran S; Bates I; Shakur-Still H;
    Trials; 2018 Dec; 19(1):712. PubMed ID: 30594227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HALT-IT--tranexamic acid for the treatment of gastrointestinal bleeding: study protocol for a randomised controlled trial.
    Roberts I; Coats T; Edwards P; Gilmore I; Jairath V; Ker K; Manno D; Shakur H; Stanworth S; Veitch A
    Trials; 2014 Nov; 15():450. PubMed ID: 25409738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic and pharmaco-biological, dose-ranging multicentre trial to determine the optimal dose of TRAnexamic acid to reduce blood loss in haemorrhagic CESarean delivery (TRACES): study protocol for a randomised, double-blind, placebo-controlled trial.
    Bouthors AS; Hennart B; Jeanpierre E; Baptiste AS; Saidi I; Simon E; Lannoy D; Duhamel A; Allorge D; Susen S
    Trials; 2018 Mar; 19(1):148. PubMed ID: 29490682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of early outcome events on the effect of tranexamic acid in post-partum haemorrhage: an exploratory subgroup analysis of the WOMAN trial.
    Brenner A; Shakur-Still H; Chaudhri R; Fawole B; Arulkumaran S; Roberts I;
    BMC Pregnancy Childbirth; 2018 Jun; 18(1):215. PubMed ID: 29879947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tranexamic acid for acute gastrointestinal bleeding (the HALT-IT trial): statistical analysis plan for an international, randomised, double-blind, placebo-controlled trial.
    Brenner A; Afolabi A; Ahmad SM; Arribas M; Chaudhri R; Coats T; Cuzick J; Gilmore I; Hawkey C; Jairath V; Javaid K; Kayani A; Mutti M; Nadeem MA; Shakur-Still H; Stanworth S; Veitch A; Roberts I;
    Trials; 2019 Jul; 20(1):467. PubMed ID: 31362765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT.
    Sprigg N; Flaherty K; Appleton JP; Al-Shahi Salman R; Bereczki D; Beridze M; Ciccone A; Collins R; Dineen RA; Duley L; Egea-Guerrero JJ; England TJ; Karlinski M; Krishnan K; Laska AC; Law ZK; Ovesen C; Ozturk S; Pocock SJ; Roberts I; Robinson TG; Roffe C; Peters N; Scutt P; Thanabalan J; Werring D; Whynes D; Woodhouse L; Bath PM
    Health Technol Assess; 2019 Jul; 23(35):1-48. PubMed ID: 31322116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tranexamic acid for preventing postpartum haemorrhage.
    Novikova N; Hofmeyr GJ; Cluver C
    Cochrane Database Syst Rev; 2015 Jun; (6):CD007872. PubMed ID: 26079202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRAAP2 - TRAnexamic Acid for Preventing postpartum hemorrhage after cesarean delivery: a multicenter randomized, doubleblind, placebo- controlled trial - a study protocol.
    Sentilhes L; Daniel V; Deneux-Tharaux C;
    BMC Pregnancy Childbirth; 2020 Jan; 20(1):63. PubMed ID: 32005192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tranexamic acid in the routine treatment of postpartum hemorrhage in the United States: a cost-effectiveness analysis.
    Sudhof LS; Shainker SA; Einerson BD
    Am J Obstet Gynecol; 2019 Sep; 221(3):275.e1-275.e12. PubMed ID: 31226298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial.
    HALT-IT Trial Collaborators
    Lancet; 2020 Jun; 395(10241):1927-1936. PubMed ID: 32563378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic tranexamic acid for reducing intraoperative blood loss during cesarean section in women at high risk of postpartum hemorrhage: A double-blind placebo randomized controlled trial.
    Ortuanya KE; Eleje GU; Ezugwu FO; Odugu BU; Ikechebelu JI; Ugwu EO; Eke AC; Awkadigwe FI; Ezenwaeze MN; Ofor IJ; Okafor CC; Okafor CG
    Womens Health (Lond); 2024; 20():17455057231225311. PubMed ID: 38279808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study protocol. TRAAP - TRAnexamic Acid for Preventing postpartum hemorrhage after vaginal delivery: a multicenter randomized, double-blind, placebo-controlled trial.
    Sentilhes L; Daniel V; Darsonval A; Deruelle P; Vardon D; Perrotin F; Le Ray C; Senat MV; Winer N; Maillard F; Deneux-Tharaux C
    BMC Pregnancy Childbirth; 2015 Jun; 15():135. PubMed ID: 26071040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high-dose 24-hour tranexamic acid infusion for the treatment of significant gastrointestinal bleeding: HALT-IT RCT.
    Roberts I; Shakur-Still H; Afolabi A; Akere A; Arribas M; Austin E; Bal K; Bazeer N; Beaumont D; Brenner A; Carrington L; Chaudhri R; Coats T; Gilmore I; Halligan K; Hussain I; Jairath V; Javaid K; Kayani A; Lisman T; Mansukhani R; Miners A; Mutti M; Nadeem MA; Pollok R; Prowse D; Simmons J; Stanworth S; Veitch A; Williams J
    Health Technol Assess; 2021 Oct; 25(58):1-86. PubMed ID: 34663491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol for a pilot, randomised, double-blinded, placebo-controlled trial of prophylactic use of tranexamic acid for preventing postpartum haemorrhage (TAPPH-1).
    Alam A; Bopardikar A; Au S; Barrett J; Callum J; Kiss A; Choi S
    BMJ Open; 2017 Oct; 7(10):e018586. PubMed ID: 29025850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of prophylactic intravenous tranexamic acid on blood loss after vaginal delivery in women at low risk of postpartum haemorrhage: a double-blind randomised controlled trial.
    Mirghafourvand M; Mohammad-Alizadeh S; Abbasalizadeh F; Shirdel M
    Aust N Z J Obstet Gynaecol; 2015 Feb; 55(1):53-8. PubMed ID: 25688820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranexamic Acid for the Prevention of Blood Loss after Cesarean Delivery.
    Sentilhes L; Sénat MV; Le Lous M; Winer N; Rozenberg P; Kayem G; Verspyck E; Fuchs F; Azria E; Gallot D; Korb D; Desbrière R; Le Ray C; Chauleur C; de Marcillac F; Perrotin F; Parant O; Salomon LJ; Gauchotte E; Bretelle F; Sananès N; Bohec C; Mottet N; Legendre G; Letouzey V; Haddad B; Vardon D; Madar H; Mattuizzi A; Daniel V; Regueme S; Roussillon C; Benard A; Georget A; Darsonval A; Deneux-Tharaux C;
    N Engl J Med; 2021 Apr; 384(17):1623-1634. PubMed ID: 33913639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.